KROS - Keros Therapeutics Inc
11.27
-0.310 -2.751%
Share volume: 625,841
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$11.58
-0.31
-0.03%
Summary score
44%
Profitability
43%
Dept financing
19%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-4.48%
Return on sales
-31320.25%
Return on invested capital
0%
Total debt ratio
7.42%
Debt ratio change over timeo
0%
Current Ratio
21.46%
Quick Ratio
0%
Cash Position Ratio
20.37%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.88%
Return on sales
-2546.16%
Return on invested capital
0%
Total debt ratio
7.57%
Debt ratio change over timeo
0%
Current Ratio
21.53%
Quick Ratio
0%
Cash Position Ratio
20.39%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-8.58%
Return on sales
-7602.6%
Return on invested capital
0%
Total debt ratio
10.32%
Debt ratio change over time
0%
Current Ratio
15.45%
Quick Ratio
0%
Cash Position Ratio
14.08%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KROS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -4.48% | 4.74% | 3.19% | 1.73% |
| Return on sales | -31320.25% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 7.42% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 2% | 21% | 16% | 50% |
| Current Ratio | 21.53% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 20.39% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 27% | 26% | 20% |
| Short-term ratios | KROS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.88% | 6.06% | 4.18% | 1.7% |
| Return on sales | -2546.16% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 62% | 50% | 34% | 23% |
| Total debt ratio | 7.57% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 20% | 15% | 25% |
| Current Ratio | 21.53% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 20.39% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 27% | 21% | 14% |